Financials
Financial year 2026
TAKEDA BELGIUM from Zaventem, company number BE0403054202, closed financial year 2026 with a result of € 3.9 million after tax. For that financial year TAKEDA BELGIUM recorded revenue of € 207.4 million and equity of € 56.5 million. Compared with financial year 2025, the result moved from € 4.2 million to € 3.9 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 8, 2026.
€ 56.5 million
▲ 7% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3.9 million
▼ 6% vs 2025
Profit after tax over the fiscal year.
€ 159,785
▲ 82% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 51 million.
People and assets in 2026
78.8
▲ 0.2 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 15.7 million
▼ 4% vs 2025
€ 198,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 237,842
▼ 22% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 6.2 million
▼ 26% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 14 days on average.
€ 5.3 million
▼ 8% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 160,394,550 | € 179,916,764 | € 201,445,269 | € 207,447,980 | ▲ 3% |
| Profit after taxes | € 5,482,828 | € 10,949,584 | € 4,173,425 | € 3,930,220 | ▼ 6% |
| Equity | € 37,485,356 | € 48,434,939 | € 52,608,364 | € 56,538,585 | ▲ 7% |
| Total debts | € 30,847,637 | € 26,295,532 | € 30,019,878 | € 29,879,213 | |
| Cash | € 2,239 | € 81,483 | € 87,999 | € 159,785 | ▲ 82% |
| Retained profit | € 31,907,501 | € 42,857,085 | € 47,030,509 | € 50,960,730 | ▲ 8% |
| Balance sheet total | € 68,446,655 | € 74,843,315 | € 82,741,086 | € 86,417,798 | ▲ 4% |
| Employees (FTE) | 76.3 | 76.4 | 78.6 | 78.8 | ▲ 0.2 |
Key figures of TAKEDA BELGIUM, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to TAKEDA BELGIUM?
What happened at TAKEDA BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Paul De Proft stepped down as director. NBB
- Aline Vandecappelle stepped down as director. NBB
- Bruno Rabillier stepped down as director. NBB
- New annual accounts for financial year 2026: profit of € 3.9 million (▼ 6% vs 2025). Source: NBB ↗
- Aline Vandecappelle became a director. NBB
- Bruno Rabillier became a director. NBB
- Paul De Proft became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 5.5 million profit in 2023 to € 3.9 million profit in 2026.
Paid € 10.3 million in corporate taxes since 2023.
Best year ever: 2024, with € 10.9 million profit.
Pays suppliers within 14 days on average.
Management
The shares are held by Takeda Pharmaceutical International AG (100%).
Directors
According to the 2026 annual accounts
Aline Vandecappelle
Director
since 2025 · until 2029
Bruno Rabillier
Managing director
since 2025 · until 2029
Paul De Proft
Director
since 2025 · until 2031
Shareholders
Takeda Pharmaceutical International AG
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 7
1930 Zaventem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →IQVIA Solutions Belgium
€ 33.1 million revenue · 2025
IQVIA RDS & INTEGRATED SERVICES BELGIUM
€ 45.6 million revenue · 2025
IM ASSOCIATES
€ 3.1 million gross margin · 2025
Orifarm Healthcare
€ 31.3 million revenue · 2025
IQVIA Cancer Research
€ 50,247 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0403.054.202
- VAT number
- BE 0403.054.202
- Registered office
- Da Vincilaan 7, 1930 Zaventem
- Names & denominations
- TAKEDA BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 June 1945
- Peppol
- Active · Active since 26 Feb 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering